首页> 外文期刊>Frontiers in Immunology >A Novel Vaccine Delivery Model of the Apicomplexan Eimeria tenella Expressing Eimeria maxima Antigen Protects Chickens against Infection of the Two Parasites
【24h】

A Novel Vaccine Delivery Model of the Apicomplexan Eimeria tenella Expressing Eimeria maxima Antigen Protects Chickens against Infection of the Two Parasites

机译:一种表达 Eimeria maxima 抗原的复合体 Eimeria tenella 新型疫苗递送模型可以保护鸡免受两种寄生虫的感染。

获取原文
           

摘要

Vaccine delivery is critical in antigen discovery and vaccine efficacy and safety. The diversity of infectious diseases in humans and livestock has required the development of varied delivery vehicles to target different pathogens. In livestock animals, previous strategies for the development of coccidiosis vaccines have encountered several hurdles, limiting the development of multiple species vaccine formulations. Here, we describe a novel vaccine delivery system using transgenic Eimeria tenella expressing immunodominant antigens of Eimeria maxima . In this delivery system, the immune mapped protein 1 of E. maxima (EmIMP1) was delivered by the closely related species of E. tenella to the host immune system during the whole endogenous life cycle. The overexpression of the exogenous antigen did not interfere with the reproduction and immunogenicity of transgenic Eimeria . After immunization with the transgenic parasite, we detected EmIMP1’s and E. maxima oocyst antigens’ specific humoral and cellular immune responses. In particular, we observed partial protection of chickens immunized with transgenic E. tenella against subsequent E. maxima infections. Our results demonstrate that the transgenic Eimeria parasite is an ideal coccidia antigen delivery vehicle and represents a new type of coccidiosis vaccines. In addition, this model could potentially be used in the development of malaria live sporozoite vaccines, in which antigens from different strains can be expressed in the vaccine strain.
机译:疫苗递送对抗原发现以及疫苗效力和安全性至关重要。人畜共患传染病的多样性要求开发针对不同病原体的多种运载工具。在牲畜中,以前的球虫病疫苗开发策略遇到了几个障碍,限制了多种疫苗制剂的开发。在这里,我们描述了一种新型的疫苗传递系统,该系统使用了表达最大艾美球虫免疫优势抗原的转基因艾美球虫艾美体。在此传递系统中,大肠埃希菌的免疫定位蛋白1(EmIMP1)在整个内源性生命周期中都由紧密相关的大肠埃希菌物种传递到宿主免疫系统。外源抗原的过表达不会干扰转基因艾美球虫的繁殖和免疫原性。用转基因寄生虫免疫后,我们检测到EmIMP1和最大大肠杆菌卵囊抗原的特定体液和细胞免疫反应。特别地,我们观察到用转基因大肠杆菌进行免疫的鸡对随后的最大大肠杆菌感染具有部分保护作用。我们的结果表明,转基因艾美球虫寄生虫是一种理想的球虫抗原传递载体,代表了一种新型的球虫病疫苗。另外,该模型可以潜在地用于疟疾活子孢子疫苗的开发中,其中来自不同菌株的抗原可以在疫苗菌株中表达。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号